WAY-262611

This product is for research use only, not for human use. We do not sell to patients.

WAY-262611
For small sizes, please check our retail website as below: www.invivochem.com
Size Price Stock
250mg$1020Check With Us
500mg$1480Check With Us
1g$2220Check With Us

Cat #: V3007 CAS #: 1123231-07-1 Purity ≥ 98%

Description: WAY-262611 (WAY262611) is a novel agonist of the wingless β-Catenin pathway with the potential for the treatment of bone disorders.

References: Pelletier JC, et al. (1-(4-(Naphthalen-2-yl)pyrimidin-2-yl)piperidin-4-yl)methanamine: a wingless beta-catenin agonist that increases bone formation rate. J Med Chem. 2009 Nov 26;52(22):6962-5.

Top Publications Citing Invivochem Products
Publications Citing InvivoChem Products

Product Promise

Promise
Molecular Weight (MW)318.42
Molecular FormulaC20H22N4
CAS No.1123231-07-1
Storage-20℃ for 3 years in powder formrr
-80℃ for 2 years in solvent
Solubility In VitroDMSO: ≥ 42 mg/mLrr
Water: <1 mg/mLrr
Ethanol: <1 mg/mL
Solubility In VivoNCC1CCN(C2=NC=CC(C3=CC=C4C=CC=CC4=C3)=N2)CC1
SynonymsWAY 262611; WAY-262611; WAY262611; WAY-262611 HCl
ProtocolIn VitroWAY-262611 has the most potent activity in the primary assay, low kinase inhibition potential, and high solubility
In VivoWAY-262611 has excellent pharmacokinetic properties and shows a dose dependent increase in the trabecular bone formation rate in ovariectomized rats following oral administration. Calvariae from wt mice treated with WAY-262611 shows statistically increased BFR, while similarly treated KO animals are no different from control. This indicates that WAY-262611 is acting via the Wnt β-catenin pathway and most likely through inhibition of Dkk-1
These protocols are for reference only. InvivoChem does not independently validate these methods.
Preparing Stock Solutions
Solvent volume to be added Mass (the weight of a compound)
Mother liquor concentration 1mg5mg10mg20mg
1mM3.1405 mL15.7025 mL31.4051 mL62.8101 mL
5mM0.6281 mL3.1405 mL6.2810 mL12.5620 mL
10mM0.3141 mL1.5703 mL3.1405 mL6.2810 mL
20mM0.1570 mL0.7851 mL1.5703 mL3.1405 mL
Quality Control Documentation
The molarity calculator equation
Mass(g) = Concentration(mol/L) × Volume(L) × Molecular Weight(g/mol)
Mass
=
Concentration
×
Volume
×
Molecular Weight*
The dilution calculator equation
Concentration(start) × Volume(start) = Concentration(final) × Volume(final)

This equation is commonly abbreviated as: C1 V1 = C2 V2

Concentration(start)
C1
×
Volume(start)
V1
=
Concentration(final)
C2
×
Volume(final)
V2
Step One: Enter information below
Dosage mg/kg Average weight of animals g Dosing volume per animal µL Number of animals
Step Two: Enter the in vivo formulation
%DMSO + % + %Tween 80 + %ddH2O

Calculation Results:
Working concentration: mg/ml;
Method for preparing DMSO master liquid: mg drug pre-dissolved in µL DMSO(Master liquid concentration mg/mL) ,Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.
Method for preparing in vivo formulation: Take µL DMSO master liquid, next add µL PEG300, mix and clarify, next add µL Tween 80,mix and clarify, next add µL ddH2O,mix and clarify.
Note:
  • (1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
  • (2) Be sure to add the solvent(s) in order.